Artery_Plaque - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Medicines Company’s inclisiran meets all endpoints in ORION-10 trial

European Commission grants orphan drug status to SpringWorks’ desmoid tumours drug. Credit: Dimitris Vetsikas from Pixabay.